Maximal Wall Thickness Measurement in Hypertrophic Cardiomyopathy: Biomarker Variability and its Impact on Clinical Care.
暂无分享,去创建一个
S. Petersen | R. Kwong | P. Nihoyannopoulos | H. Watkins | S. Neubauer | T. Wong | P. Elliott | J. Moon | R. Nezafat | C. Manisty | A. Fraser | R. Ariga | I. Olivotto | G. Captur | A. Nasis | G. Lloyd | S. Nakamori | M. Westwood | Carolyn Y. Ho | Chunming Li | V. Patel | E. Ormondroyd | Savvas Loizos | A. Marchi | A. Turer | B. Raman | A. Bhuva | R. Davies | V. Zaha | C. Camaioni | D. Pérez de Arenaza | A. Taylor | L. Tang | I. Lobascio | M. Al-Mallah | Sinitsyn Valentin | Jenade Bonsu-Ofori | João B. Augutsto
[1] M. Link,et al. Enhanced American College of Cardiology/American Heart Association Strategy for Prevention of Sudden Cardiac Death in High-Risk Patients With Hypertrophic Cardiomyopathy. , 2019, JAMA cardiology.
[2] A. Keren,et al. International External Validation Study of the 2014 European Society of Cardiology Guidelines on Sudden Cardiac Death Prevention in Hypertrophic Cardiomyopathy (EVIDENCE-HCM) , 2017, Circulation.
[3] R. Chan,et al. Discrepant Measurements of Maximal Left Ventricular Wall Thickness Between Cardiac Magnetic Resonance Imaging and Echocardiography in Patients With Hypertrophic Cardiomyopathy , 2017, Circulation. Cardiovascular imaging.
[4] N. Smedira,et al. Comparison of Ventricular Septal Measurements in Hypertrophic Cardiomyopathy Patients Who Underwent Surgical Myectomy Using Multimodality Imaging and Implications for Diagnosis and Management. , 2017, The American journal of cardiology.
[5] C. Rinaldi,et al. Usefulness of Cardiac Magnetic Resonance Imaging to Measure Left Ventricular Wall Thickness for Determining Risk Scores for Sudden Cardiac Death in Patients With Hypertrophic Cardiomyopathy. , 2017, The American journal of cardiology.
[6] S. Ommen,et al. Comparison of Maximal Wall Thickness in Hypertrophic Cardiomyopathy Differs Between Magnetic Resonance Imaging and Transthoracic Echocardiography. , 2017, The American journal of cardiology.
[7] J. Moon,et al. Why democratise bioinformatics? , 2016, BMJ Innovations.
[8] A. Wilde,et al. Implantable cardioverter-defibrillator harm in young patients with inherited arrhythmia syndromes: A systematic review and meta-analysis of inappropriate shocks and complications. , 2016, Heart rhythm.
[9] Michael F. McNitt-Gray,et al. Determining the Variability of Lesion Size Measurements from CT Patient Data Sets Acquired under “No Change” Conditions12 , 2015, Translational oncology.
[10] Martin Borggrefe,et al. [2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy]. , 2014, Kardiologia polska.
[11] Giuseppe Limongelli,et al. A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD). , 2014, European heart journal.
[12] M. Maron,et al. Clinical Utility of Cardiovascular Magnetic Resonance in Hypertrophic Cardiomyopathy , 2012, Journal of Cardiovascular Magnetic Resonance.
[13] Barry J Maron,et al. 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, American Soci , 2011, Journal of the American College of Cardiology.
[14] P. Harris,et al. Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support , 2009, J. Biomed. Informatics.
[15] A. Tajik,et al. Hypertrophic cardiomyopathy: identification of morphological subtypes by echocardiography and cardiac magnetic resonance imaging. , 2008, JACC. Cardiovascular imaging.
[16] Eloisa Arbustini,et al. Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. , 2007, European heart journal.
[17] A. Devlin,et al. A comparison of MRI and echocardiography in hypertrophic cardiomyopathy. , 1999, The British journal of radiology.
[18] E. E. van der Wall,et al. Assessment of quantitative hypertrophy scores in hypertrophic cardiomyopathy: magnetic resonance imaging versus echocardiography. , 1996, American heart journal.
[19] M. Eliasziw,et al. Statistical methodology for the concurrent assessment of interrater and intrarater reliability: using goniometric measurements as an example. , 1994, Physical therapy.
[20] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .